Stock Ideas
Stocks
Funds
Screener
Sectors
Watchlists

Latest Blue Owl Capital Holdings LP Stock Portfolio

$359Million– No. of Holdings #41

Blue Owl Capital Holdings LP Performance:
2024 Q2: -5.73%YTD: 2.14%2023: 35.04%

Performance for 2024 Q2 is -5.73%, and YTD is 2.14%, and 2023 is 35.04%.

About Blue Owl Capital Holdings LP and 13F Hedge Fund Stock Holdings

In it's latest 13F Holdings report, Blue Owl Capital Holdings LP reported an equity portfolio of $359.6 Millions as of 30 Jun, 2024.

The top stock holdings of Blue Owl Capital Holdings LP are CGEM, PLRX, . The fund has invested 9.9% of it's portfolio in CULLINAN THERAPEUTICS INC and 9% of portfolio in PLIANT THERAPEUTICS INC.

The fund managers got completely rid off ROBINHOOD MKTS INC (HOOD), MOONLAKE IMMUNOTHERAPEUTICS (MLTX) and DELL TECHNOLOGIES INC (DELL) stocks. They significantly reduced their stock positions in ENGENE HOLDINGS INC, CULLINAN THERAPEUTICS INC (CGEM) and IMMUNOVANT INC (IMVT). Blue Owl Capital Holdings LP opened new stock positions in CONTEXT THERAPEUTICS INC (CNTX), VIKING THERAPEUTICS INC (VKTX) and STARWOOD PROPERTY TRUST (STWD). The fund showed a lot of confidence in some stocks as they added substantially to DISC MEDICINE INC, AQUESTIVE THERAPEUTICS INC (AQST) and REPARE THERAPEUTICS INC (RPTX).
Blue Owl Capital Holdings LP Equity Portfolio Value
Last Reported on: 15 Aug, 2024

Blue Owl Capital Holdings LP Annual Return Estimates Vs S&P 500

Our best estimate is that Blue Owl Capital Holdings LP made a return of -5.73% in the last quarter. In trailing 12 months, it's portfolio return was 14.49%.

New Buys

Ticker$ Bought
context therapeutics inc10,348,400
viking therapeutics inc5,035,950
starwood property trust4,289,080
pyxis oncology inc3,462,340
mereo biopharma group plc3,232,110
structure therapeutics inc2,159,850
janux therapeutics inc1,675,600
celcuity inc1,064,700

New stocks bought by Blue Owl Capital Holdings LP

Additions

Ticker% Inc.
disc medicine inc38.64
aquestive therapeutics inc30.29
tourmaline bio inc18.52
repare therapeutics inc8.01
ikena oncology inc5.14
acelyrin inc3.54

Additions to existing portfolio by Blue Owl Capital Holdings LP

Reductions

Ticker% Reduced
engene holdings inc-89.99
cullinan therapeutics inc-29.94
immunovant inc-20.00
mineralys therapeutics inc-16.77
inozyme pharma inc-11.81
keros therapeutics inc-8.69
larimar therapeutics inc-3.38
engene holdings inc-0.47

Blue Owl Capital Holdings LP reduced stake in above stock

Sold off

Ticker$ Sold
robinhood mkts inc-53,984,600
ovid therapeutics inc-2,637,710
black diamond therapeutics i-3,523,650
direxion shs etf tr-3,572,100
rallybio corp-647,944
starwood property trust-2,361,390
moonlake immunotherapeutics-5,023,000
desktop metal inc-660,000

Blue Owl Capital Holdings LP got rid off the above stocks

Sector Distribution

Blue Owl Capital Holdings LP has about 49.1% of it's holdings in Healthcare sector.

Sector%
Healthcare49.1
Others39.7
Technology9.7
Real Estate1.2

Market Cap. Distribution

Blue Owl Capital Holdings LP has about 2.3% of it's portfolio invested in the large-cap and mega-cap stocks.

Category%
UNALLOCATED41.2
SMALL-CAP33.5
MID-CAP11.8
MICRO-CAP11.2
LARGE-CAP2.3

Stocks belong to which Index?

About 43.5% of the stocks held by Blue Owl Capital Holdings LP either belong to S&P 500 or RUSSELL 2000 index.

Index%
Others56.5
RUSSELL 200043.5
Top 5 Winners (%)%
APTM
plum acquisition corp iii
APTM
plum acquisition corp iii
DM
desktop metal inc
362.6 %
EVCM
evercommerce inc
16.6 %
IKNA
ikena oncology inc
16.6 %
Top 5 Winners ($)$
CGEM
cullinan therapeutics inc
5.9 M
EVCM
evercommerce inc
2.6 M
IKNA
ikena oncology inc
1.0 M
CNTX
context therapeutics inc
0.8 M
APTM
plum acquisition corp iii
0.3 M
Top 5 Losers (%)%
CMPX
compass therapeutics inc
-49.5 %
OMGA
omega therapeutics inc
-43.3 %
INZY
inozyme pharma inc
-41.6 %
AQST
aquestive therapeutics inc
-34.9 %
KROS
keros therapeutics inc
-30.0 %
Top 5 Losers ($)$
PLRX
pliant therapeutics inc
-12.5 M
RPTX
repare therapeutics inc
-4.4 M
INZY
inozyme pharma inc
-4.0 M
KROS
keros therapeutics inc
-3.4 M
CMPX
compass therapeutics inc
-2.8 M

Blue Owl Capital Holdings LP Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Blue Owl Capital Holdings LP

Blue Owl Capital Holdings LP has 41 stocks in it's portfolio. About 68% of the portfolio is in top 10 stocks. PLRX proved to be the most loss making stock for the portfolio. CGEM was the most profitable stock for Blue Owl Capital Holdings LP last quarter.

Last Reported on: 15 Aug, 2024
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions